| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 17,333 | 18,338 | 19,152 | 20,522 | | Cost of Revenue | (16,516) | 15,836 | 16,156 | 17,544 | | | Gross Profit | 33,849 | 2,502 | 2,996 | 2,978 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 33,264 | 1,632 | 1,687 | 1,865 | | Non Recurring | 57 | 267 | 52 | 5,312 | | Others | 892 | 885 | 868 | 947 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (510) | (282) | 390 | (5,146) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (139) | 10 | 11 | 9 | | Earnings Before Interest And Taxes | (502) | (272) | 401 | (5,137) | | Interest Expense | 40 | 43 | 62 | 103 | | Income Before Tax | (542) | (314) | 339 | (5,239) | | Income Tax Expense | (310) | (63) | 66 | (1,306) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (233) | (252) | 273 | (3,933) | | | Non-recurring Events | | Discontinued Operations | 196 | 44 | (93) | 16 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (233) | (208) | 180 | (3,917) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($233) | ($208) | $180 | ($3,917) |
|
0.51% Nasdaq 
Income Statement
